To include your compound in the COVID-19 Resource Center, submit it here.

BCRX reports delay in flu program

BioCryst (BCRX) partner R.W. Johnson Pharmaceutical Research Institute, a subsidiary of Johnson

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE